Annals of Surgical Oncology

, Volume 24, Issue 6, pp 1569–1578 | Cite as

Complications after Hepatectomy for Hepatocellular Carcinoma Independently Shorten Survival: A Western, Single-Center Audit

  • Alexandre Doussot
  • Chetana Lim
  • Eylon Lahat
  • Chady Salloum
  • Michael Osseis
  • Concepción Gómez Gavara
  • Eric Levesque
  • Cyrille Feray
  • Philippe Compagnon
  • Daniel AzoulayEmail author
Hepatobiliary Tumors



The impact of postoperative complications (POCs) on long-term outcomes following hepatocellular carcinoma (HCC) resection remains to be ascertained.


All consecutive HCC resected at a single center were analyzed. Patients with POCs, classified according to Clavien classification, were compared to those without in terms of demographics, pathology, management, overall survival (OS), and disease-free survival (DFS). Independent prognostic factors of POCs were identified using multivariable regression models.


Among 341 patients, overall POCs rate was 34% (n = 116) and grade III–IV POCs rate was 14.4% (n = 49). POCs were an independent negative factor for OS [hazard ratio (HR) 1.40, 95% confidence interval (CI) 1.12–2.26, p = 0.009] with BCLC stage, the need for combined procedure, intraoperative transfusion, and the METAVIR score of the underlying parenchyma. Similarly, occurrence of POCs was associated independently with DFS (HR 1.59, 95% CI 1.18–2.15, p = 0.002), together with the presence of portal hypertension, BCLC stage, the need for combined procedure, intraoperative transfusion, and the presence of satellite nodules. After stratification, the negative impact of morbidity on OS and DFS reached statistical significance in the BCLC stage A subset only (p = 0.026, and p < 0.001, respectively). Open resection, intraoperative transfusion, and the existence of underlying liver injury were independent predictors of POCs.


POCs should be considered as a long-term prognostic factor. Careful patient selection requiring underlying liver assessment and appropriate strategy, such as mini-invasive surgery and restricted transfusion policy, might be promoted to prevent POCs.


Overall Survival Portal Hypertension Portal Vein Embolization Laparoscopic Liver Resection Barcelona Clinic Liver Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Llovet JM, Ducreux M, Lencioni R, et al. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908–43.CrossRefGoogle Scholar
  2. 2.
    Bruix J, Sherman M. American association for the study of liver diseases. management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Torzilli G, Belghiti J, Kokudo N, et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? An observational study of the HCC East-West study group. Ann Surg. 2013;257(5):929–37.CrossRefPubMedGoogle Scholar
  4. 4.
    Yin L, Li H, Li AJ, et al. Partial hepatectomy versus transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT. J Hepatol. 2014;61(1):82–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Fan ST, Poon RT, Yeung C, et al. Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria. Br J Surg. 2011;98(9):1292–300.CrossRefPubMedGoogle Scholar
  6. 6.
    Mazzaferro V, Romito R, Schiavo M, et al. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology. 2006;44:1543–54.CrossRefPubMedGoogle Scholar
  7. 7.
    Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008;134:1908–16.CrossRefPubMedGoogle Scholar
  8. 8.
    Makuuchi M, Sano K. The surgical approach to HCC: our progress and results in Japan. Liver Transpl. 2004;10:S46–S52.CrossRefPubMedGoogle Scholar
  9. 9.
    -Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005;25:181–200.CrossRefPubMedGoogle Scholar
  10. 10.
    Shim JH, Jun MJ, Han S, et al. Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma. Ann Surg. 2015;261(5):939–46.CrossRefPubMedGoogle Scholar
  11. 11.
    Kusano T, Sasaki A, Kai S, et al. Predictors and prognostic significance of operative complications in patients with hepatocellular carcinoma who underwent hepatic resection. Eur J Surg Oncol. 2009;35(11):1179–85.CrossRefPubMedGoogle Scholar
  12. 12.
    Eappen S, Lane BH, Rosenberg B, et al. Relationship between occurrence of surgical complications and hospital finances. JAMA. 2013;309(15):1599–606.CrossRefPubMedGoogle Scholar
  13. 13.
    De Melo GM, Ribeiro KC, Kowalski LP, Deheinzelin D. Risk factors for postoperative complications in oral cancer and their prognostic implications. Arch Otolaryngol Head Neck Surg. 2001;127(7):828–33.PubMedGoogle Scholar
  14. 14.
    Mirnezami A, Mirnezami R, Chandrakumaran K, et al. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg. 2011;253(5):890–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Andalib A, Ramana-Kumar AV, Bartlett G, et al. Influence of postoperative infectious complications on long-term survival of lung cancer patients: a population-based cohort study. J Thorac Oncol. 2013;8(5):554–61.CrossRefPubMedGoogle Scholar
  16. 16.
    Ito H, Are C, Gonen M, et al. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg. 2008;247(6):994–1002.CrossRefPubMedGoogle Scholar
  17. 17.
    Farid SG, Aldouri A, Morris-Stiff G, et al. Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg. 2010;251(1):91–100.CrossRefPubMedGoogle Scholar
  18. 18.
    Laurent C, Sa Cunha A, Couderc P, et al. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg. 2003;90(9):1131–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Mavros MN, de Jong M, Dogeas E, et al. Impact of complications on long-term survival after resection of colorectal liver metastases. Br J Surg. 2013;100(5):711–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Spolverato G, Yakoob MY, Kim Y, et al. Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma. Cancer. 2015;121(16):2730–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Chok KS, Ng KK, Poon RT, et al. Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg. 2009;96(1):81–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Ruan DY, Lin ZX, Li Y, et al. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy. World J Gastroenterol. 2015;21(18):5598–606.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Mizuguchi T, Kawamoto M, Meguro M, et al. Prognosis and predictors of surgical complications in hepatocellular carcinoma patients with or without cirrhosis after hepatectomy. World J Surg. 2013;37(6):1379–87.CrossRefPubMedGoogle Scholar
  24. 24.
    Okamura Y, Takeda S, Fujii T, et al. Prognostic significance of postoperative complications after hepatectomy for hepatocellular carcinoma. J Surg Oncol. 2011;104(7):814–21.CrossRefPubMedGoogle Scholar
  25. 25.
    Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol. 2001;35:421–30.CrossRefPubMedGoogle Scholar
  26. 26.
    Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–36.CrossRefPubMedGoogle Scholar
  27. 27.
    Mayo SC, Shore AD, Nathan H, et al. Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB. 2011;13(7):473–82.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    The METAVIR Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994;20(1):15–20.CrossRefGoogle Scholar
  29. 29.
    Azoulay D, Castaing D, Krissat J, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg. 2000;232:665–72.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Kluger MD, Salceda JA, Laurent A, et al. Liver resection for hepatocellular carcinoma in 313 Western patients: tumor biology and underlying liver rather than tumor size drive prognosis. J Hepatol. 2015;62:1131–40.CrossRefPubMedGoogle Scholar
  31. 31.
    Santambrogio R, Kluger MD, Costa M, et al. Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh’s A cirrhosis: is clinical evidence of portal hypertension a contraindication? HPB. 2013;15(1):78–84.CrossRefPubMedGoogle Scholar
  32. 32.
    Couinaud C. Le foie: études anatomiques et chirurgicales. Masson, Paris, 1957.Google Scholar
  33. 33.
    Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713–24.CrossRefPubMedGoogle Scholar
  34. 34.
    Koch M, Garden OJ, Padbury R, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery. 2011;149(5):680–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Rahbari NN, Garden OJ, Padbury R, et al. Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB. 2011;13(8):528–35.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Dindo D, Demartines N, Clavien PA. Classification of Surgical Complications: A New Proposal with Evaluation in a Cohort of 6336 Patients and Results of a Survey. Ann Surg. 2004;240(2):205–13.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Benchimol EI, Langan S, Guttmann A, RECORD Steering Committee. Call to RECORD: the need for complete reporting of research using routinely collected health data. J Clin Epidemiol. 2013;66(7):703–5.CrossRefPubMedGoogle Scholar
  38. 38.
    Cauchy F, Fuks D, Nomi T, et al. Risk factors and consequences of conversion in laparoscopic major liver resection. Br J Surg. 2015;102(7):785–95.CrossRefPubMedGoogle Scholar
  39. 39.
    Han HS, Shehta A, Ahn S, et al. Laparoscopic versus open liver resection for hepatocellular carcinoma: case-matched study with propensity score matching. J Hepatol. 2015;63(3):643–50.CrossRefPubMedGoogle Scholar
  40. 40.
    Sposito C, Battiston C, Facciorusso A, et al. Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma. Br J Surg. 2016;103(7):871–80.CrossRefPubMedGoogle Scholar
  41. 41.
    Han DH, Choi SH, Park EJ, et al. Surgical outcomes after laparoscopic or robotic liver resection in hepatocellular carcinoma: a propensity-score matched analysis with conventional open liver resection. Int J Med Robot 2015 Nov 4. Epub ahead of print.Google Scholar
  42. 42.
    Komatsu S, Brustia R, Goumard C, et al. Laparoscopic versus open major hepatectomy for hepatocellular carcinoma: a matched pair analysis. Surg Endosc. 2016;30(5):1965–74.CrossRefPubMedGoogle Scholar
  43. 43.
    Cucchetti A, Ercolani G, Vivarelli M, et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl. 2006;12:966–71.CrossRefPubMedGoogle Scholar
  44. 44.
    Worhunsky DJ, Dua MM, Tran TB, et al. Laparoscopic hepatectomy in cirrhotics: safe if you adjust technique. Surg Endosc. 2016;1–8.Google Scholar
  45. 45.
    Kawaguchi Y, Nomi T, Fuks D, et al. Hemorrhage control for laparoscopic hepatectomy: technical details and predictive factors for intraoperative blood loss. Surg Endosc. 2016;30(6):2543–51.CrossRefPubMedGoogle Scholar
  46. 46.
    Shehta A, Han HS, Yoon YS, et al. Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: 10-year single-center experience. Surg Endosc. 2016;30(2):638–48.CrossRefPubMedGoogle Scholar
  47. 47.
    Buettner S, Gani F, Amini N, et al. The relative effect of hospital and surgeon volume on failure to rescue among patients undergoing liver resection for cancer. Surgery. 2015;159(4):1004–12.CrossRefPubMedGoogle Scholar
  48. 48.
    Lim C, DeJong CH, Farges O; e-HPBchir Study Group from the Association de Chirurgie Hépato-Biliaire et de Transplantation (ACHBT) (Association of Hepatobiliary and Transplant Surgery). Improving the quality of liver resection: a systematic review and critical analysis of the available prognostic models. HPB. 2015;17(3):209–21.Google Scholar
  49. 49.
    Yamashita Y, Yoshida Y, Kurihara T, et al. Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: repeat hepatectomy versus salvage living donor liver transplantation. Liver Transpl. 2015;21(7):961–8.CrossRefPubMedGoogle Scholar
  50. 50.
    Mise Y, Hasegawa K, Shindoh J, et al. The feasibility of third or more repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg. 2015;262(2):347–57.CrossRefPubMedGoogle Scholar
  51. 51.
    Scatton O, Zalinski S, Terris B, et al. Hepatocellular carcinoma developed on compensated cirrhosis: Resection as a selection tool for liver transplantation. Liver Transpl. 2008;14:779–88.CrossRefPubMedGoogle Scholar
  52. 52.
    Bhangui P, Allard MA, Vibert E, et al. Salvage versus primary liver transplantation for early hepatocellular carcinoma: do both strategies yield similar outcomes? Ann Surg. 2015;264(1):155–163.CrossRefGoogle Scholar
  53. 53.
    Tribillon E, Barbier L, Goumard C, et al. When should we propose liver transplant after resection of hepatocellular carcinoma? A comparison of salvage and de Principe strategies. J Gastrointest Surg. 2016;20(1):66–76.CrossRefPubMedGoogle Scholar
  54. 54.
    Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Bioemtrika. 1983;70(1):41–55.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2016

Authors and Affiliations

  • Alexandre Doussot
    • 1
  • Chetana Lim
    • 1
  • Eylon Lahat
    • 1
  • Chady Salloum
    • 1
  • Michael Osseis
    • 1
  • Concepción Gómez Gavara
    • 1
  • Eric Levesque
    • 2
  • Cyrille Feray
    • 3
  • Philippe Compagnon
    • 1
    • 4
  • Daniel Azoulay
    • 1
    • 4
    Email author
  1. 1.Department of Hepatopancreatobiliary Surgery and Liver Transplantation, Hôpital Henri MondorAssistance Publique-Hôpitaux de Paris, AP-HPCréteilFrance
  2. 2.Department of Anesthesiology and Intensive Care, Hôpital Henri MondorAssistance Publique-Hôpitaux de Paris, AP-HPCréteilFrance
  3. 3.Department of Hepatology, Hôpital Henri MondorAssistance Publique-Hôpitaux de Paris, AP-HPCréteilFrance
  4. 4.INSERM 955CréteilFrance

Personalised recommendations